Target intelligence / Profile preview

Ribosomal protein L27 pseudogene 8 (RPL27P8)

Target
RPL27P8
Molecular classification
Other (pseudogene)
01

Overview

RPL27P8 (ribosomal protein L27 pseudogene 8) is a processed pseudogene corresponding to the ribosomal protein L27 gene (RPL27), meaning it is a genomic DNA sequence similar to RPL27 but typically nonfunctional, generated by retrotranspositional events[1][6]. Ribosomal protein pseudogenes are abundant in the human genome, usually do not produce functional proteins, and are not considered classical therapeutic targets. RPL27P8 lacks evidence for coding capacity or clear biological function, differentiating it from functional ribosomal proteins or their rare coding paralogs[1][3][6]. - RPL27 is the parent gene; pseudogenes like RPL27P8 typically arise via retrotransposition and are widespread byproducts of ribosomal protein gene expression in mammals[3][5][6]. - No evidence supports a biological role, disease association, or utility as a drug target or biomarker for RPL27P8 itself[1][4][6]. - There are rare exceptions among ribosomal pseudogenes where they become functional, but no such evidence exists for RPL27P8[3][6]. Key points: - RPL27P8 is not a protein, receptor, enzyme, nor a validated drug target. - It is a pseudogene—a non-coding, typically nonfunctional DNA sequence derived from a functional ribosomal protein gene[1][6]. - Inclusion as a drug target or disease marker is not supported by current scientific data.

Other names
RPL27_3_316RPL27P8

Beyond the preview

Go deeper on Ribosomal protein L27 pseudogene 8 (RPL27P8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L27 pseudogene 8 (RPL27P8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call